Date
Research Firm
Action
Current
PT
11/12/19
TD Securities
Downgrades
Hold
45.0
Data powered by
Benzinga Pro Calendars
-
Start your FREE TRIAL today!
Sign up to receive Benzinga's Daily Ratings Newsletter
Recent Ratings
SAGE
(Downgrades)
SAGE
(Downgrades)
DD
(Upgrades)
PHG
(Upgrades)
DO
(Downgrades)
VAL
(Downgrades)
BORR
(Downgrades)
NE
(Downgrades)
ANTM
(Downgrades)
CIEN
(Downgrades)
News Coverage
Zoom Video Sells Off After Q3 Earnings Print
Bank Of America Looks At Colorado Sales In Monthly Cannabis Tracker
3 Analysts Debate Kroger's Stock Following Q3 Earnings
Benzinga's Top Upgrades, Downgrades For December 6, 2019
Biogen Analysts Divided Over Alzheimer's Drug Following CTAD Presentation
Morgan Stanley Raises Tesla's Stock Bull Case On China, Cybertruck Opportunities
10 Biggest Price Target Changes For Friday
GrubHub Still Has Some Work To Do, Analyst Says After Deep Dive Into Food Delivery Business
Biogen's CTAD Presentation On Aducanumab Elicits Mixed Response
Street Is Bullish On Five Below After Q3 Sales Beat